Drug intelligence / Profile preview

vitex agnus-castus fruit extract

Development stage
Phase 3
Lead developer
Bionorica
Modality
Small Molecules
Administration
Oral
01

Overview

Vitex agnus-castus fruit extract, commonly known as chasteberry, is a herbal medicine used primarily for the treatment of gynecological conditions. Its therapeutic effects are largely attributed to its dopaminergic activity; specifically, it contains diterpenes that act as agonists at the dopamine D2 receptors in the anterior pituitary. This action suppresses the secretion of prolactin, which is often elevated in women with premenstrual syndrome (PMS) and cyclic mastodynia. By lowering prolactin levels, the extract helps normalize the luteal phase of the menstrual cycle and alleviate breast pain. Beyond its established use in PMS, the extract is being investigated for its ability to reduce mammographic breast density, potentially serving as an adjunct in breast cancer screening to improve diagnostic clarity. Key pharmaceutical developers include Bionorica, which markets the extract under the brand Agnucaston and as a component of the combination product Mastodynon.

Brand names
AgnucastonMastodynonFemicurRemisens
Other names
Chasteberry extractChaste tree fruit extractMönchspfefferKeuschlamm
02

Targets

DOR (Opioid Receptor Delta 1)DRD2 (Dopamine D2 Receptor)MOR (Mu opioid receptor)

Beyond the preview

Go deeper on vitex agnus-castus fruit extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on vitex agnus-castus fruit extract.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call